14 hours Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

GILD has put up a steady performance in 2024, with a new drug approval, positive data readouts and strong quarterly results. We believe there is more room for growth, given GILD’s strong fundamentals.

Biotech · Gilead (GILD)

14 hours Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

1 day Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks

2 days 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks

2 days KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks

2 days Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks

2 days Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily

3 days GILD’s Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer Zacks

3 days Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

3 days 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance

3 days Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure Seeking Alpha

3 days Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

4 days How to play a potential biotech breakout in 2025 with options CNBC

4 days 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

4 days 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks

5 days GILD Obtains Positive CHMP Opinion for Liver Disease Drug Zacks

5 days Gilead (GILD) Upgraded to Buy: Here’s Why Zacks

5 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

5 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

5 days Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance

1 week Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know Zacks

1 week KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks

1 week Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Investing.com

1 week RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch

1 week Is Gilead Sciences (GILD) Stock Undervalued Right Now? Zacks

1 week Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 week The Ultimate Biotech Stock to Buy With $500 Right Now Yahoo Finance

1 week Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

1 week Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks

1 week Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily

1 week Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily

1 week Final Trade: LMAT, GOOGL, IBM, GILD YouTube

2 weeks Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

2 weeks NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug Investor's Business Daily

2 weeks CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease MarketWatch

2 weeks Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

2 weeks Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Zacks

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

2 weeks Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Investor's Business Daily

2 weeks Wuxi, China biotech stocks surge on hopes of less severe US sanctions Investing.com

2 weeks 2 Biotech Stocks to Buy Hand Over Fist in December Yahoo Finance

2 weeks CRL Stock to Gain From the Global Biotech Incubator Program Launch Zacks

2 weeks MacroGenics: A Productive Biotech With Growing Potential – Still Not A Buy Seeking Alpha

2 weeks Legend Biotech: The Story Brightens Seeking Alpha

2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks

2 weeks Gilead Sciences Is Turning Itself Around. Why Its Stock Can Keep Rallying. Yahoo Finance

2 weeks Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

2 weeks Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? Zacks

2 weeks Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC Zacks

2 weeks Roivant Sciences: A Biotech Growth Play With Major Ambitions Seeking Alpha

3 weeks Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha

The Stock Market News